Skip to content

Endovascular Function in Atrial Fibrillation (AF) Patients

Endovascular Function in Patients With Atrial Fibrillation

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02062957
Acronym
HEAF
Enrollment
80
Registered
2014-02-14
Start date
2014-02-28
Completion date
Unknown
Last updated
2014-02-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

PAT Result

Brief summary

1. recruit 50 patients with atrial fibrillation and 30 controls 2. endovascular function assessment with Peripheral Arterial Tonometry (PAT) 3. follow up the occurence of AF

Interventions

None listed

Sponsors

Beijing Chao Yang Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* ≥2 paroxysmal (electrocardiographic documentation of at least 1) AF episodes lasting ≥1 hour in duration: (that terminate spontaneously within 7 days or cardioversion is performed within 48h of AF onset): or * electrocardiographic documentation of 1 persistent AF episode: (sustained for ≥7 days or cardioversion is performed more than 48h after AF onset): or * electrocardiographic documentation of 1 longstanding persistent AF episode: (continuous AF of duration \>1 year).

Exclusion criteria

* patients with cerebralvascular disease * patients with coronary disease * patients with peripheric artery disease

Design outcomes

Primary

MeasureTime frameDescription
endovascular function resultsUp to 24 weeks.The method to assess the endovascular function is PAT. The index is Reactive hyperemia index (RHI). RHI between patients and control will be compared.

Secondary

MeasureTime frameDescription
predictive effect of endovascular function on recurrence of AFUp to 1 yearWe will do the multi-logistic analysis of the recurrence of AF.

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026